DAIC

JULY 18, 2024

mtaschetta-millane Thu, 07/18/2024 - 10:00 July 18, 2024 — HeartFlow, Inc. , a leader in non-invasive artificial intelligence (AI) heart care solutions, introduced the next generation HeartFlow Plaque Analysis with an interactive experience. This upgraded platform is the only plaque analysis tool fully integrated with FFR CT (when FFR CT is performed), delivering impactful insights to enhance clinical decision-making and enabling personalized patient treatment plans.

Coronary Artery Disease 111

Coronary Artery Disease Plaque Technology Medicare 111

Ken Grauer, MD

JULY 18, 2024

How would YOU interpret the rhythm in Figure-1 — if you were sent this tracing without the benefit of any history? Figure-1: How would YOU interpret this rhythm? The "Quick" Answer: My initial thoughts on the rhythm in Figure-1 : The rhythm in Figure-1 is not completely regular. That said — the R-R interval for the first 5 beats looks regular. The R-R interval for the last few beats is shorter than this — but also regular.

Blog 87

Blog Arrhythmia Bradycardia Pacemaker 87

DAIC

JULY 18, 2024

Circle Cardiovascular Imaging has announced that Erkan Akyuz has been appointed Chief Executive Officer to succeed Circle co-founder and CEO Greg Ogrodnick. Image courtesy: Circle Cardiovascular christine.book Thu, 07/18/2024 - 13:32 July 18, 2024 — Circle Cardiovascular Imaging , a developer of artificial intelligence (AI)-driven cardiovascular imaging solutions, has announced that Erkan Akyuz has been appointed Chief Executive Officer, effective August 5, 2024.

Cardiovascular Imaging 105

Cardiovascular Imaging Innovation Technology Hospital 105

Nature Reviews - Cardiology

JULY 18, 2024

Nature Reviews Cardiology, Published online: 19 July 2024; doi:10.1038/s41569-024-01063-5 Contraction of the heart is driven by cyclical interactions between myosin and actin filaments driven by ATP hydrolysis. In this Review, Irving summarizes the basal cardiac cycle of the healthy human heart at the ventricular, cellular, sarcomeric, and molecular levels and the implications for the development of novel therapies for heart disease.

Heart Disease 92

Heart Disease 92

DAIC

JULY 18, 2024

mtaschetta-millane Thu, 07/18/2024 - 09:19 July 18, 2024 — Elucid , a pioneering AI medical technology company providing physicians with imaging analysis software based on ground truth histology to support diagnosis and treatment of cardiovascular disease, has initiated site recruitment for its Plaque as a Risk Factor for Evaluation of Vascular Events (PRE-VUE) CT Registry Study.

Plaque 105

Plaque Heart attacks Heart Attack Cardiovascular Disease 105

HCPLive

JULY 18, 2024

Adalimumab-adbm is now available at a 92% discount from the reference drug list price through GoodRx.

111

111

DAIC

JULY 18, 2024

mtaschetta-millane Thu, 07/18/2024 - 09:05 July 18, 2024 — AliveCor , a global leader in AI-powered cardiology , today announced that the American Medical Association (AMA) has granted new Category III Current Procedural Terminology (CPT) codes that are applicable to the company's Kardia 12L ECG System , which received FDA clearance in June 2024.

Reimbursement 105

Reimbursement Electrocardiogram Technology Medicaid 105

Nature Reviews - Cardiology

JULY 18, 2024

Nature Reviews Cardiology, Published online: 19 July 2024; doi:10.1038/s41569-024-01047-5 During commercial spaceflight, individuals who might have underlying cardiovascular disease will be exposed to increased gravitational and acceleration (G) forces. In this Review, Morris and colleagues explore the use of computational models to simulate the effects of G forces on human cardiovascular pathophysiology to risk-stratify individuals and help to improve safety in commercial suborbital spaceflight

Cardiovascular Disease 72

Cardiovascular Disease 72

Journal of Cardiothoracic Surgery

JULY 18, 2024

The impact of nitric oxide (NO) administered via cardiopulmonary bypass (CPB) on pediatric heart surgery remains controversial. The objective of this study is to conduct a comprehensive systematic review and m.

Pediatrics 69

Pediatrics 69

Becker's Hospital Review - Cardiology

JULY 18, 2024

"UC Irvine receives $50 million gift from Joe Wen and family for cardiology advancements and research, renaming divisions and center in honor of Wen's parents a

Research 69

Research 69

HCPLive

JULY 18, 2024

Phase 2 data from the ARCHER study shows a protective effect of ANX007 on visual acuity and anatomical measures in the central macula in patients with GA.

64

64

American College of Cardiology

JULY 18, 2024

What are the effectiveness and safety outcomes associated with apixaban versus rivaroxaban and versus warfarin in patients with cirrhosis and atrial fibrillation (AF)?

Atrial Fibrillation 63

Atrial Fibrillation Outcomes Article 63

HCPLive

JULY 18, 2024

Vonoprazan (Voquenza), the first major innovation in GERD treatment in more than 30 years, is now FDA-approved for both erosive and non-erosive GERD.

Innovation 64

Innovation 64

The American Journal of Cardiology

JULY 18, 2024

Publication date: Available online 18 July 2024 Source: The American Journal of Cardiology Author(s): Safia Shaikh, Mohammad Hamza, Prakash Upreti, Mohammad Akkawi, Kripa Rajak, Mobeen Zaka Haider, Nomesh Kumar, Mustafa Turkmani, Fadi Kathawa, Salman Abdul Basit, Yasemin Bahar, Sadaf Fakhra, Yasar Sattar, M Chadi Alraies

Angioplasty 52

Angioplasty Stent Stents 52

HCPLive

JULY 18, 2024

Katherine Talcott, MD describes a posthoc analysis of the GATHER trials showing how imaging biomarkers of photoreceptor structure predict GA growth.

Biomarkers 64

Biomarkers 64

Journal of Cardiothoracic Surgery

JULY 18, 2024

Analyze the pattern of lymph node metastasis in Siewert II adenocarcinoma of the esophagogastric junction (AEG) and provide a basis for the principles of surgical access.

52

52

HCPLive

JULY 18, 2024

Announced on July 18, 2024, the FDA approval for heartburn relief associated with non-erosive GERD is based on the phase 3 PHALCON-NERD-301 trial.

64

64

American College of Cardiology

JULY 18, 2024

What are the national trends in utilization of leadless pacemaker implantation following transcatheter aortic valve replacement (TAVR) and its performance compared with transvenous pacemakers?

TAVR 56

TAVR Pacemaker Aortic valve Aortic 56

HCPLive

JULY 18, 2024

OTX-TKI remained generally well-tolerated in patients with moderately severe to severe NPDR across 48 weeks of the Phase 1 trial.

69

69

Becker's Hospital Review - Cardiology

JULY 18, 2024

"Learn how AirLift Texas emergency air crews are now equipped to transport cardiac patients with intra-aortic balloon pumps, providing faster and safer access t

Aortic 52

Aortic 52

HCPLive

JULY 18, 2024

In this Q&A interview, Stein Gold discusses new phase 3 findings regarding ruxolitinib cream 1.5% for patients 2 to 11 years old with atopic dermatitis.

59

59

American College of Cardiology

JULY 18, 2024

The Centers for Medicare and Medicaid Services (CMS) released the proposed 2025 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System rule on July 10. CMS proposes a 2.6% increase to OPPS payment rates that reflects a market basket update of 3.0% reduced by a productivity adjustment of 0.4%.

Hospital 48

Hospital CMS Medicaid Medicare 48

HCPLive

JULY 18, 2024

Sorana Segal-Maurer, MD, offers clinical insights on treating patients with HIV who have viral mutations, including M184V, highlighting guideline recommendations.

52

52

The American Journal of Cardiology

JULY 18, 2024

Publication date: Available online 17 July 2024 Source: The American Journal of Cardiology Author(s): Pedro Piccaro de Oliveira, Anibal P. Abelin, Guilherme Pinheiro Machado, Evandro M. Filho, Gustavo N. Araujo, Leandro A. Côrtes, Lucio Padilla, Sebastian Pablo Peralta, Ricardo Santiago, João E.T. de Paula, Antonio Carlos Botelho, Mauro Echavarria-Pinto, Felix Damas de los Santos, Marcelo H.

40

40

HCPLive

JULY 18, 2024

Younger adults (aged 20 – 40 years) with OSA were 3 times more likely to experience any type of CVD event than those without OSA.

Cardiovascular Disease 59

Cardiovascular Disease 59

The American Journal of Cardiology

JULY 18, 2024

Publication date: Available online 17 July 2024 Source: The American Journal of Cardiology Author(s): Gani Bajraktari, Ibadete Bytyçi, Genc Abdyli, Pranvera Ibrahimi, Artan Bajraktari, Rona Karahoda, Shpend Elezi, Michael Y.

Thrombosis 52

Thrombosis Stent Stents 52

HCPLive

JULY 18, 2024

The XTEND-Kids phase 3 trial shows efanesoctocog alfa’s safety and efficacy in children with severe hemophilia A, reducing bleeds with once-weekly dosing.

52

52

The American Journal of Cardiology

JULY 18, 2024

Publication date: Available online 17 July 2024 Source: The American Journal of Cardiology Author(s): Michael Kachmar, Florina Corpodean, Courtney LaChute, Iryna Popiv, Michael Cook, Denise M Danos, Vance L Albaugh, Denzil L Moraes, WH Wilson Tang, Philip R Schauer

Heart Failure 40

Heart Failure Outcomes 40

HCPLive

JULY 18, 2024

Shawn Kwatra, MD, discusses the durability of treatments for atopic dermatitis and provides advice for clinicians on improving patients’ quality of life.

Quality of Life 52

Quality of Life 52

The American Journal of Cardiology

JULY 18, 2024

Publication date: Available online 18 July 2024 Source: The American Journal of Cardiology Author(s): Daniel S. Matasic, Ralph Zeitoun, Gregg C. Fonarow, Alexander C. Razavi, Roger S.

Heart Failure 40

Heart Failure 40

HCPLive

JULY 18, 2024

An academic dermatologist discusses the safety profiles of abrocitinib and upadacitinib and provides clinical insights on patient monitoring practices.

Academic 52

Academic 52

NEJM Journal Watch - Cardiology

JULY 18, 2024

A randomized trial showed benefits for patients with or without diabetes or prior stroke.

Diabetes 40

Diabetes Stroke Strokes 40

HCPLive

JULY 18, 2024

Ruth Ann Vleugels, MD, MPH, MBA, provides insights on factors that inform JAK inhibitor treatment selection for patients with atopic dermatitis.

52

52

Journal of Cardiovascular Pharmacology

JULY 18, 2024

An abstract is unavailable. This article is available as a PDF only.

Myocardial Infarction 40

Myocardial Infarction Article Outcomes 40

HCPLive

JULY 18, 2024

Shawn Kwatra, MD, provides an overview of oral JAK inhibitors for the treatment of atopic dermatitis, highlighting data from clinical trials.

Quality of Life 52

Quality of Life 52

HCPLive

JULY 18, 2024

An expert on atopic dermatitis identifies patients who are good candidates for JAK inhibitors, highlighting contraindications for treatment.

52

52

HCPLive

JULY 18, 2024

The novel potassium-competitive acid blocker now boasts 3 FDA approvals across erosive and non-erosive GERD, expanding the treatment armamentarium for patients and clinicians.

Innovation 49

Innovation 49